Mukka Proteins Ltd
Mukka Proteins Ltd (MUKKA) last reported results for the quarter ended Jun 2026, with sales of ₹490 crore and net profit of ₹19 crore. The stock last traded at ₹26.5, a market capitalisation of ₹795 crore, on a P/E of 11.5. Over the past 52 weeks the stock has ranged between ₹18.3 and ₹33.3. Figures are as of 6 Oct 2026 and are not real time.
Mukka Proteins Ltd share price and key metrics
- Current price
- ₹26.5
- Market cap
- ₹795 cr
- Stock P/E
- 11.5
- Book value
- ₹16.6
- ROE
- 11.1%
- ROCE
- 11.6%
- Dividend yield
- 0.00%
- 52w high / low
- 33.3/18.3
Metrics as of 6 Oct 2026. Not real time.
Track Mukka Proteins Ltd
Cruxal reads every Mukka Proteins Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Mukka Proteins Ltd growth and returns
- 10 Years
- %
- 5 Years
- 19%
- 3 Years
- 7%
- TTM
- 76%
- 10 Years
- %
- 5 Years
- 53%
- 3 Years
- 6%
- TTM
- 59%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- 1 Year
- -1%
- 10 Years
- %
- 5 Years
- 17%
- 3 Years
- 14%
- Last Year
- 11%
Mukka Proteins Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹490 cr, up 186.5% from ₹171 cr a year earlier. Net profit was ₹19 cr, up 850.0% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 149 | 303 | 382 | 171 | 245 | 654 | 381 | 490 |
| Expenses | 140 | 262 | 352 | 157 | 224 | 608 | 347 | 443 |
| Operating profit | 10 | 41 | 29 | 14 | 20 | 45 | 34 | 47 |
| OPM % | 6% | 14% | 8% | 8% | 8% | 7% | 9% | 10% |
| Other income | 4 | 6 | 4 | 3 | 6 | 8 | 15 | 2 |
| Interest | 9 | 11 | 10 | 11 | 13 | 15 | 15 | 16 |
| Depreciation | 4 | 4 | 3 | 3 | 4 | 4 | 5 | 5 |
| Profit before tax | 1 | 33 | 20 | 2 | 9 | 35 | 29 | 27 |
| Tax % | -40% | 19% | 30% | 33% | 26% | 21% | 26% | 32% |
| Net profit | 1 | 27 | 14 | 2 | 7 | 27 | 21 | 19 |
| EPS (₹) | 0.07 | 0.88 | 0.45 | 0.05 | 0.20 | 0.79 | 0.69 | 0.63 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Mukka Proteins Ltd annual results
| ₹ crore | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 409 | 549 | 604 | 770 | 1,177 | 1,380 | 1,006 | 1,449 | 1,768 |
| Operating profit | 23 | 24 | 22 | 48 | 86 | 105 | 95 | 115 | 147 |
| OPM % | 6% | 4.3% | 3.6% | 6% | 7% | 8% | 9% | 8% | 8% |
| Net profit | 14 | 14 | 11 | 26 | 48 | 74 | 48 | 57 | 74 |
| EPS (₹) | — | — | — | 1.10 | 2.00 | 2.34 | 1.55 | 1.74 | 2.31 |
TTM is the trailing twelve months to the most recent quarter.
Mukka Proteins Ltd balance sheet
| ₹ crore | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 6 | 6 | 6 | 22 | 22 | 30 | 30 | 30 |
| Reserves | 38 | 51 | 61 | 76 | 126 | 366 | 411 | 469 |
| Borrowings | 83 | 142 | 159 | 175 | 262 | 365 | 453 | 779 |
| Other liabilities | 74 | 95 | 129 | 119 | 166 | 179 | 183 | 343 |
| Total liabilities | 201 | 293 | 355 | 392 | 575 | 941 | 1,076 | 1,621 |
| Fixed assets | 49 | 78 | 79 | 83 | 85 | 85 | 94 | 194 |
| CWIP | 0 | 2 | 4 | 0 | 0 | 0 | 9 | 31 |
| Investments | 8 | 4 | 12 | 21 | 21 | 31 | 37 | 56 |
| Other assets | 144 | 209 | 260 | 289 | 469 | 825 | 937 | 1,341 |
| Total assets | 201 | 293 | 355 | 392 | 575 | 941 | 1,076 | 1,621 |
As reported by the company. Total assets equal total liabilities by construction.
Mukka Proteins Ltd cash flow
| ₹ crore | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | -20 | -25 | 2 | 5 | -56 | -150 | -112 | -111 |
| Cash from investing | -23 | -28 | -14 | -11 | -3 | -48 | -35 | -146 |
| Cash from financing | 34 | 54 | 13 | 15 | 75 | 266 | 56 | 267 |
| Net cash flow | -9 | 1 | 2 | 8 | 15 | 68 | -91 | 10 |
| Free cash flow | -39 | -61 | -8 | -1 | -64 | -165 | -130 | -230 |
| CFO / operating profit | -67% | -81% | 29% | 22% | -52% | -118% | -114% | -84% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Mukka Proteins Ltd operating ratios
| Per year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | — | 15% | 9% | 18% | 24% | 19% | 12% | 12% |
| Debtor days | 25 | 23 | 29 | 29 | 35 | 49 | 72 | 46 |
| Inventory days | 95 | 89 | 106 | 95 | 89 | 136 | 266 | 267 |
| Days payable | 63 | 63 | 71 | 56 | 51 | 44 | 67 | 75 |
| Cash conversion cycle | 57 | 49 | 64 | 68 | 73 | 141 | 272 | 238 |
| Working capital days | 4 | -9 | -12 | -1 | 10 | 45 | 99 | 45 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Mukka Proteins Ltd shareholding pattern
Promoters held 73.33% at Jun 2026, broadly unchanged since Jun 2025. FIIs 1.73% and DIIs 0.00%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 73.33% | 73.33% | 73.33% | 73.33% | 73.33% | 73.33% | 73.33% | 73.33% |
| FIIs | 2.81% | 2.63% | 2.63% | 2.08% | 1.70% | 1.70% | 1.70% | 1.73% |
| DIIs | 2.00% | 1.98% | 1.98% | 1.87% | 1.66% | 0.17% | 0.00% | 0.00% |
| Public | 21.84% | 22.06% | 22.05% | 22.71% | 23.31% | 24.80% | 24.97% | 24.93% |
| No. of shareholders | 1,44,549 | 1,46,062 | 1,47,308 | 1,45,343 | 1,41,649 | 1,37,920 | 1,32,098 | 1,27,922 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Mukka Proteins Ltd corporate filings
- Mukka Proteins Ltd announces commencement of commercial production at overseas subsidiaryCompany Updatelow impact
Cruxal's analysis: The company has informed that its overseas subsidiary has started commercial production…
Read the full analysis - Mukka Proteins Ltd grants corporate guarantee and security, no immediate financial impact reportedCompany Updatelow impact
Cruxal's analysis: On October 9, 2026, Mukka Proteins Ltd announced the issuance of a corporate guarantee…
Read the full analysis - Mukka Proteins Limited receives reaffirmed credit ratings from CARE Ratings with a stable outlook, reflecting improved operating performance in Q1FY27 driven by rising global fish meal prices and steady demand.Company Updatehigh impact
Cruxal's analysis: Mukka Proteins Limited has secured a credit rating reaffirmation from CARE Ratings for…
Read the full analysis - Intimation of Compliance Certificate under Reg 74 (5) of SEBI (DP) Regulations.Company Updatelow impact
- Mukka Proteins Ltd receives USDA NOP Inputs Attestation on 6 October 2026Company Updatelow impact
Cruxal's analysis: The company, a small-cap with a market cap of approximately 787.8 crore, announced…
Read the full analysis - Mukka Proteins Limited delays strategic acquisition of Aqua Marine, revising completion date to January 2027Company Updatemedium impact
Cruxal's analysis: Mukka Proteins Limited has announced a delay in executing its planned acquisition of 51%…
Read the full analysis - Intimation of closure of Trading Window.Insider Trading / SASTlow impact
- Mukka Proteins Ltd schedules analyst/institutional investor meetingCompany Updatelow impact
Cruxal's analysis: Mukka Proteins Ltd has issued an intimation regarding a scheduled meeting with analysts…
Read the full analysis - Mukka Proteins Ltd schedules analyst/institutional investor meetingCompany Updatelow impact
Cruxal's analysis: Mukka Proteins Ltd has issued an intimation regarding a scheduled meeting with analysts…
Read the full analysis - Mukka Proteins Ltd schedules analyst/investor meetingCompany Updatelow impact
Cruxal's analysis: Mukka Proteins Ltd has issued an intimation regarding a scheduled analyst/investor…
Read the full analysis - Mukka Proteins Ltd schedules analyst/investor meeting for September 12, 2026Company Updatelow impact
Cruxal's analysis: Mukka Proteins Ltd has issued an intimation regarding a scheduled analyst/investor…
Read the full analysis - Mukka Proteins Limited Announces Successful Conclusion of 16th AGM and Approval of Key ResolutionsAGM/EGMlow impact
Cruxal's analysis: Mukka Proteins Limited has successfully concluded its 16th Annual General Meeting held on…
Read the full analysis - Mukka Proteins Limited Announces Re-appointment of Key Management Personnel and Independent DirectorsCompany Updatelow impact
Cruxal's analysis: Mukka Proteins Limited has formally approved the re-appointment of its Managing Director…
Read the full analysis - Mukka Proteins Limited concludes 16th Annual General Meeting; seeks shareholder approval for increased borrowing limitsAGM/EGMlow impact
Cruxal's analysis: Mukka Proteins Limited has successfully concluded its 16th Annual General Meeting held on…
Read the full analysis - Mukka Proteins Limited Allots 2 Crore Convertible Warrants to Non-Promoters Raising 47 Crore INRCompany Updatehigh impact
Cruxal's analysis: Mukka Proteins Limited has successfully allotted 2 crore convertible warrants to 15…
Read the full analysis - Mukka Proteins Limited to Acquire 16.77% Stake in Shipwaves Online Limited for INR 13.19 CroreCompany Updatemedium impact
Cruxal's analysis: Mukka Proteins Limited has announced a strategic investment of INR 13.19 crore to acquire…
Read the full analysis - Mukka Proteins Ltd files routine press release intimationCompany Updatelow impact
Cruxal's analysis: Mukka Proteins Ltd has submitted a formal intimation regarding the release of a press…
Read the full analysis - Mukka Proteins Limited Receives In-Principle Approval for Preferential Issue of 2 Crore Convertible Warrants at INR 23.50 per shareCompany Updatemedium impact
Cruxal's analysis: Mukka Proteins Limited has secured in-principle approval from both NSE and BSE to issue 2…
Read the full analysis - Mukka Proteins issues clarification regarding investment in Swaccha Eco Solutions Private LimitedCompany Updatelow impact
Cruxal's analysis: Mukka Proteins has issued a clarification regarding its previous intimation dated 12th…
Read the full analysis - Mukka Proteins Ltd announces 16th Annual General Meeting notice publicationCompany Updatelow impact
Cruxal's analysis: Mukka Proteins Ltd has issued a formal intimation regarding the publication of the notice…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.